Published in Cancer Weekly, August 26th, 2003
Researchers at Vanderbilt have moved a step closer to that scenario with the identification of a distinct pattern of expression of 15 proteins in lung cancers that can predict a poor prognosis or a good prognosis. All patients in the poor prognosis group had died 1 year after diagnosis, while all patients in the good prognosis group were still alive. Median survival, the point at which half the patients were still alive, was 6 months for the poor prognosis group, compared to 33 months for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.